These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Delta-8- and delta-9-tetrahydrocannabinol comparison in man by oral and intravenous administration. Hollister LE; Gillespie HK Clin Pharmacol Ther; 1973; 14(3):353-7. PubMed ID: 4698563 [No Abstract] [Full Text] [Related]
3. Depression of growth hormone and cortisol response to insulin-induced hypoglycemia after prolonged oral delta-9-tetrahydrocannabinol administration in man. Benowitz NL; Jones RT; Lerner CB J Clin Endocrinol Metab; 1976 May; 42(5):938-41. PubMed ID: 1270583 [TBL] [Abstract][Full Text] [Related]
4. A study of teratological effects of intravenous, subcutaneous, and intragastric administration of delta9-tetrahydrocannabinol in mice. Joneja MG Toxicol Appl Pharmacol; 1976 Apr; 36(1):151-62. PubMed ID: 1273835 [No Abstract] [Full Text] [Related]
5. Effects of delta-9-tetrahydrocannabinol on halothane MAC in dogs. Stoelting RK; Martz RC; Gartner J; Creasser C; Brown DJ; Forney RB Anesthesiology; 1973 Jun; 38(6):521-4. PubMed ID: 4706747 [No Abstract] [Full Text] [Related]
6. Effects of orally administered delta-9-tetrahydrocannabinol in man. Hosko MJ; Kochar MS; Wang RI Clin Pharmacol Ther; 1973; 14(3):344-52. PubMed ID: 4698562 [No Abstract] [Full Text] [Related]
7. A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man. Perez-Reyes M; Timmons MC; Lipton MA; Christensen HD; Davis KH; Wall ME Experientia; 1973 Aug; 29(8):1009-10. PubMed ID: 4582081 [No Abstract] [Full Text] [Related]
8. Lack of tolerance to the bradycardic effect of delta 9-trans-tetrahydrocannabinol in rats. Kaymakçalan S; Sivil S Pharmacology; 1974; 12(4-5):290-5. PubMed ID: 4449891 [No Abstract] [Full Text] [Related]
9. Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol. Hollister LE; Gillespie H Clin Pharmacol Ther; 1975 Jul; 18(1):80-3. PubMed ID: 1097148 [TBL] [Abstract][Full Text] [Related]
10. Cannabis and alcohol: effects on stimulated car driving. Rafaelsen OJ; Bech P; Christiansen J; Christrup H; Nyboe J; Rafaelsen L Science; 1973 Mar; 179(4076):920-3. PubMed ID: 4569248 [TBL] [Abstract][Full Text] [Related]
11. Effects of repeated doses of l-delta 8-trans-tetrahydrocannabinol on schedule-controlled temporally-spaced responding of rats. Frankenheim JM Psychopharmacologia; 1974; 38(2):125-44. PubMed ID: 4460069 [No Abstract] [Full Text] [Related]
12. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol. Pertwee RG Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752 [TBL] [Abstract][Full Text] [Related]
13. Cannabidiol interferes with the effects of delta 9 - tetrahydrocannabinol in man. Karniol IG; Shirakawa I; Kasinski N; Pfeferman A; Carlini EA Eur J Pharmacol; 1974 Sep; 28(1):172-7. PubMed ID: 4609777 [No Abstract] [Full Text] [Related]
14. Analgesic effect of delta 9-tetrahydrocannabinol in the dog. Kaymakçalan S; Türker RK; Türker MN Psychopharmacologia; 1974 Feb; 35(2):123-8. PubMed ID: 4815113 [No Abstract] [Full Text] [Related]
15. Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol. Hollister LE Pharmacology; 1974; 11(1):3-11. PubMed ID: 4610598 [No Abstract] [Full Text] [Related]
17. The toxicologic and teratologic effects of delta-9-tetrahydrocannabinol in the zebrafish embryo. Thomas RJ Toxicol Appl Pharmacol; 1975 Apr; 32(1):184-90. PubMed ID: 1135874 [No Abstract] [Full Text] [Related]
18. Effect of delta-9-tetrahydrocannabinol administration on the lipid constituents of rat brain subcellular fractions. Sarkar C; Ghosh JJ J Neurochem; 1975 Feb; 24(2):381-5. PubMed ID: 1113115 [No Abstract] [Full Text] [Related]
19. Do plasma concentrations of delta 9-tetrahydrocannabinol reflect the degree of intoxication? Hollister LE; Gillespie HK; Ohlsson A; Lindgren JE; Wahlen A; Agurell S J Clin Pharmacol; 1981; 21(S1):171S-177S. PubMed ID: 6271822 [TBL] [Abstract][Full Text] [Related]
20. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Ohlsson A; Lindgren JE; Wahlen A; Agurell S; Hollister LE; Gillespie HK Clin Pharmacol Ther; 1980 Sep; 28(3):409-16. PubMed ID: 6250760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]